ECM
PLSE icon

Exchange Capital Management’s Pulse Biosciences PLSE Stock Holding History

Exchange Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,800
Closed -$26K – 226
2018
Q3 		$26K Hold
1,800
– – 0.01% 191
2018
Q2 		$27K Hold
1,800
– – 0.01% 188
2018
Q1 		$24K Hold
1,800
– – 0.01% 171
2017
Q4 		$42K Hold
1,800
– – 0.01% 153
2017
Q3 		$33K Buy
+1,800
New +$40.9K 0.01% 161

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TF
TIAA FSB Jacksonville, Florida $27.6B AUM 14.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exchange Capital Management's PLSE Position: Q4 2018 in Review

Exchange Capital Management sold out of Pulse Biosciences (PLSE) in Q4 2018, closing a stake of 1,800 shares — an estimated $26K sold.

Exchange Capital Management first reported a position in PLSE in Q3 2017 and held it in 5 quarters. The position peaked at $42K in Q4 2017. 42 funds tracked by Wall St. Rank hold PLSE as of Q4 2018.

  • Exchange Capital Management reported no remaining Pulse Biosciences position as of Q4 2018 after selling out during the quarter.
  • Exchange Capital Management sold 1,800 Pulse Biosciences shares in Q4 2018, an estimated $26K.
  • Exchange Capital Management first reported a position in Pulse Biosciences in Q3 2017 and held it in 5 quarters.
  • Exchange Capital Management's Pulse Biosciences position peaked at $42K in Q4 2017.
  • 42 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2018.

Based on Exchange Capital Management's 13F filing for Q4 2018, filed 1 Feb 2019.